Abstract
Chemical-biological (CB) interactions are governed by both the structure of the chemical and the properties of the biological system. The ability of a drug or chemical to be absorbed from the lung, skin, or gastrointestinal tract and to enter the body is a CB interaction. Unless the chemical structure is fat-soluble enough to dissolve in the lipoprotein membrane, or small enough to pass through pores, or it mimics an endogenous substance that is actively transported, the chemical cannot move across membranes or skin. Ultimately, for a chemical to exert an effect it must be absorbed and enter the blood. Once in the blood, a chemical’s further disposition is governed by its pharmacokinetic characteristics, i.e., its distribution and elimination from body compartments.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Alvares, A. P. 1978. Interactions between environmental chemicals and drug biotransformation in man. Clin. Pharmacokin. 3:462–477.
Andrews, L. S., E. W. Lee, C. M. Witmer, J. J. Kocsis, and R. Snyder. 1977. Effects of toluene on the metabolism, disposition and hematopoietic toxicity of 3H-benzene. Biochem. Pharmacol. 26:293– 300.
Andrews, L. S., J. A. Hinson, and J. R. Gillette. 1978. Studies on the mutagenicity of 7V-hydroxy-2-acetylaminofluorene in the Ames Salmonella mutagenesis test system. Biochem. Pharmacol. 27:2399–2408.
Barry, E. J., D. Malejka-Giganti, and H. R. Gutmann. 1969. Interaction of aromatic amines with rat liver proteins in vivo. III. On the mechanism of binding of the carcinogens, N-2-fluorenylacetam-ide and N-hydroxy-2-fluorenylacetamide, to the soluble proteins. Chem. Biol. Interact. 1:139–155.
Beland, F. A., K. L. Dooley, and C. D. Jackson. 1982. Persistence of DNA adducts in rat liver and kidney after multiple doses of the carcinogen N-hydroxy-2-acetylaminofluorene. Cancer Res. 42:1348–1354.
Blackburn, G. R., J. P. Andrews, R. P. Custer, and S. Soraf. 1981. Early events during liver carcinogenesis involving two carcinogenrprotein complexes. Cancer Res. 41:4039–4049.
Bolt, H. M., R. J. Laib, and J. G. Filser. 1982. Reactive metabolites and carcinogenicity of halogenated ethylenes. Biochem. Pharmacol. 31:1–4.
Boyland, E. 1950. The biological significance of metabolism of polycyclic compounds. Biochem. Soc. Symp. 5:40–54.
Conney, A. H. 1967. Pharmacological implications of microsomal enzyme induction. Pharmacol. Rev. 9:317–366.
D’Souza, M., R. Snyder, and J. J. Kocsis. 1979. Benzene inhibits ovarian hypertrophy in the hemi-spayed rat. Toxicol. Appl. Pharmacol. 40:A40.
Dutton, G. J., ed. 1966. Glucuronic Acid, Free and Combined: Chemistry, Biochemistry, Pharamacol ogy and Medicine. Academic Press, New York.
Estabrook, R. W., J. Werringloer, J. Capdevila, and R. A. Prough. 1978. The role of cytochrome P450 and the microsomal electron transport system: The oxidative metabolism of benzo(a)pyrene. Pp. 285–316 in H. A. Gelboin and P. O. P. Ts’o, eds. Polycyclic Hydrocarbons and Cancer ,Volume 1. Environment, Chemistry, and Metabolism. Academic Press, New York.
Farber, E. 1978. Experimental liver carcinogens: A perspective. Pp. 357–375 in H. Remmer, P. Bannasch, H. M. Bolt, and H. Popper ,eds. Primary Liver Tumors. MTP Press, New York.
Frommer, U., V. Ullrich, and S. Orrenius. 1974. Influence of inducers and inhibitors on the hydroxylation pattern of n-hexane in rat liver microsomes. FEBS Lett. 41:14–16.
Gillette, J. R. 1974a. A perspective on the role of chemically reactive metabolites of foreign compounds in toxicity. I. Correlation of changes in covalent binding of reactive metabolites with changes in the incidence and severity of toxicity. Biochem. Pharmacol. 23:2785–2794.
Gillette, J. R. 1974b. A perspective on the role of chemically reactive metabolites of foreign compounds in toxicity. II. Alterations in the kinetics of covalent binding. Biochem. Pharmacol. 23:2927–2938.
Gonasun, L. M., C. Witmer, J. J. Kocsis, and R. Snyder. 1973. Benzene metabolism in mouse liver microsomes. Toxicol. Appl. Pharmacol. 26:398–406.
Guengerich, F. P. 1977. Separation and purification of multiple forms of microsomal cytochrome P-450. Activities of different forms of cytochrome P-450 towards several compounds of environmental interest. J. Biol. Chem. 252:3970–3979.
Holder, G., H. Yagi, P. Dansette, D. M. Jerina, W. Levein, A. Y. H. Lu, and A. H. Conney. 1974. Effects of inducers of epoxide hydrase on the metabolism of benzo(a)pyrene by liver microsomes and a reconstituted system: Analysis by high pressure liquid chromatography. Proc. Natl. Acad. Sci. USA 71:4356–4360.
Ingleman-Sundberg, M. 1980. Bioactivation or inactivation of toxic compounds? Trends Pharmacol. Sci. 1980:176–179.
Johnson, E. F. 1979. Multiple forms of cytochrome P-450: Criteria and significance. Pp. 1–26 in E. Hodgson, J. R. Bend, and R. M. Philpot, eds. Reviews in Biochemical Toxicology ,Volume 2. Elsevier/North-Holland, New York.
Jollow, D. J., J. R. Mitchell, W. Z. Potter, D. C. Davis, J. R. Gillette, and B. B. Brodie. 1973. Acet-aminophen-induced hepatic necrosis. II. Role of covalent binding in vivo. J. Pharmacol. Exp. Ther. 187:195–202.
Jollow, D. J., J. J. Kocsis, R. Snyder, and H. Vainio, eds. 1977. Biological Reactive Intermediates: Formation, Toxicity, and Inactivation. Plenum Press, New York. 514 pp.
Jollow, D. J., S. Roberts, V. Price, and C. Smith. 1982. Biochemical basis for dose response relationships in reactive metabolite toxicity. Pp. 99–113 in R. Snyder, D. V. Parke, J. J. Kocsis, D. J. Jollow, G. G. Gibson, and C. M. Witmer, eds. Biological Reactive Intermediates II: Chemical Mechanisms and Biological Effects. Plenum Press, New York.
Kostrzewa, R. M., and D. M. Jacobowitz. 1974. Pharmacological actions of 6-hydroxy-dopamine. Pharmacol. Rev. 26:199–288.
Lawley, P. D. 1980. DNA as a target of alkylating carcinogens. Br. Med. Bull. 36:19–24.
Lesko, S. A., R. J. Lorentzen, and P. O. P. Ts’o. 1978. Benzo(a)pyrene metabolism: One-electron pathways and the role of nuclear enzymes. Pp. 261–269 in H. V. Gelboin and P. O. P. Ts’o, eds. Polycyclic Hydrocarbons and Cancer ,Volume 1. Academic Press, New York.
Lin, J. K., J. A. Miller, and E. C. Miller. 1975. On the structures of hepatic nucleic acid-bound dyes in rats given the carcinogen N-methyl-4-aminoazobenzene. Cancer Res. 35:844–850.
Longacre, S. L., J. J. Kocsis, and R. Snyder. 1981. Influence of strain differences in mice on the metabolism and toxicity of benzene. Toxicol. Appl. Pharmacol. 60:398–409.
Lutz, W. K., and C. M. Schlatter. 1977. Mechanism of carcinogenic action of benzene. Irreversible binding to rat liver DNA. Chem. Biol. Interact. 18:241–245.
Magee, P. N. 1980. Metabolism of nitrosamines: An overview. Pp. 1081–1090 in M. J. Coon, A. H. Conney, R. W. Estabrook, H. V. Gelboin, J. R. Gillette, and P. J. O’Brien, eds. Microsomes, Drug Oxidations, and Chemical Carcinogenesis. Academic Press, New York.
Mason, R. P. 1979. Free radical metabolites of foreign compounds and their toxicological significance. Pp. 151–200 in E. Hodgson ,J. R. Bend, and R. M. Philpot, eds. Reviews in Biochemical Toxicology ,Volume 1. Elsevier/North-Holland, New York.
Miller, E. C., and J. A. Miller. 1947. Presence and significance of bound aminoazo dyes in livers of rats fed p-dimethylaminoazobenzene. Cancer Res. 7:468–480.
Miller, E. C, and J. A. Miller. 1982. Reactive metabolites as key intermediates in pharmacologic and toxicologic responses. Examples from chemical carcinogenesis. Pp. 1–21 in R. Snyder, D. V. Parke ,J. J. Kocsis ,D. J. Jollow ,G. G. Gibson ,and C. M. Witmer, eds. Biological Reactive Intermediates II: Chemical Mechanisms and Biological Effects. Plenum Press, New York.
Miller, J. A. 1970. Carcinogenesis by chemicals: An overview-G. H. A. Clowes memorial lecture. Cancer Res. 30:559–576.
Miller, J. A., and E. C. Miller. 1977. The concept of reactive electrophilic metabolites in chemical carcinogenesis: Recent results with aromatic amines, safrole, and aflatoxin B1. Pp. 6–24 in D. J. Jollow, J. J. Kocsis, R. Snyder, and H. Vanio, eds. Biological Reactive Intermediates: Formation, Toxicity, and Inactivation. Plenum Press, New York.
Mitchell, J. R., and D. J. Jollow. 1974. Biochemical basis for drug-induced heptatoxicity. Isr. J. Med. Sci. 10:312–318.
Mitchell, J. R., and D. J. Jollow. 1975. Role of metabolic activation in chemical carcinogenesis in drug-induced hepatic injury. Pp. 395–416 in W. Gerok and K. Sickinger, eds. Drugs and the Liver. Schattaner, Stuttgart.
Mitchell, J. R., W. D. Reid, B. Christine, J. Moskowitz, G. Krishna, and B. B. Brodie. 1971. Bromo-benzene-induced hepatic necrosis: Species differences and protection by SKF 525-A. Res. Com-mun. Chem. Pathol. Pharmacol. 2:877–888.
Mitchell, J. R., D. J. Jollow, W. Z. Potter, D. C. Davis, J. R. Gillette, and B. B. Brodie. 1973. Acet-aminophen-induced hepatic necrosis. I. Role of drug metabolism. J. Pharmacol. Exp. Ther. 187:185–194.
Nebert, D. W., and N. M. Jensen. 1979. The Ah locus: Genetic regulation of the metabolism of carcinogens, drugs, and other environmental chemicals by cytochrome P-450-mediated monooxy-genases. CRC Crit. Rev. Biochem. 6:401–438.
Norpoth, J., U. Witting, and M. Springorum. 1974. Induction of microsomal enzymes in the rat liver by inhalation of hydrocarbon solvents. Int. Arch. Arbeitsmed. 33:315–321.
Parke, D. V. 1968. The Biochemistry of Foreign Compounds. Pergamon Press, New York.
Poirier, L. A., J. A. Miller, E. C. Miller, and K. Sato. 1967. N-Benzoyloxy-N-methyl-4-aminoazoben-zene: Its carcinogenic activity in the rat and its reactions with proteins and nucleic acids and their constituents in vitro. Cancer Res. 27:1600–1613.
Poirier, M. C., B. True, and B. A. Laishes. 1982. Formation and removal of (guan-8-yl) DNA-2-ace-tylaminofluorene adducts in liver and kidney of male rats given dietary 2-acetylaminofluorene. Cancer Res. 42:1317–1321.
Potter, W. Z., S. S. Thorgeirsson, D. J. Jollow, and J. R. Mitchell. 1974. Acetaminophen-induced hepatic necrosis. V. Correlation of hepatic necrosis, covalent binding and glutathione depletion in hamsters. Pharmacology 12:129–143.
Pound, A. W., and L. J. McGuire. 1978a. Repeated partial hepatectomy as a promoting stimulus for carcinogenic response of liver to nitrosamines in rats. Br. J. Cancer 37:585–594.
Pound, A. W., and L. J. McGuire. 1978b. Influence of repeated liver regeneration on hepatic carcinogenesis by diethylnitrosamine in mice. Br. J. Cancer 37:595–602.
Prescott, L. F., N. Wright, P. Roscoe, and S. S. Bronn. 1971. Plasma-paracentamol half-life and hepatic necrosis in patients with paracetamol overdosage. Lancet i:519–522.
Proudfoot, A. T., and N. Wright. 1970. Acute paracetamol poisoning. Br. Med. J. 3:557–558.
Recknagel, R. O. 1967. Carbon tetrachloride hepatotoxicity. Pharmacol. Rev. 19:145–208.
Roberts, S. A., and D. J. Jollow. 1978. Acetaminophen structure-toxicity relationships-Why is 3-hydroxyacetanilide not hepatotoxic? Pharmacology 20:259.
Roberts, S. A., and D. J. Jollow. 1979a. Acetaminophen structure-toxicity studies: Lack of liver necrosis after 2-hydroxyacetanilide. Pharmacology 21:220.
Roberts ,S. A., and D. J. Jollow. 1979b. Acetaminophen structure-toxicity studies-In vivo covalent binding of a non-hepatotoxic analog 3-hydroxyacetanilide. Fed. Proc. 38:426.
Roberts, S. A., and D. J. Jollow. 1980. Acetaminophen structure-toxicity studies: In vivo covalent binding of a non-hepatotoxic analog, 2-hydroxyacetanilide. Fed. Proc. 39:748.
Sammett, D., E. W. Lee, J. J. Kocsis, and R. Snyder. 1979. Partial hepatectomy reduces both the metabolism and toxicity of benzene. J. Toxicol. Environ. Health 5:785–792.
Sato, A., and T. Nakajima. 1979. Dose-dependent metabolic interaction between benzene and toluene in vivo and in vitro. Toxicol. Appl. Pharmacol. 48:249–256.
Sato, R., and T. Omura. 1978. Cytochrome P-450. Academic Press, New York. 233 pp.
Schenkman, J. B., and D. Kupfer, eds. 1982. Hepatic Cytochrome P-450 Monooxygenase System. Pergamon Press, New York.
Sims, P. 1980. The metabolic activation of chemical carcinogens. Br. Med. Bull. 36:11–18.
Smith, C. L., and D. J. Jollow. 1976. Potentiation of acetaminophen-induced liver necrosis in hamsters by galactosamine. Pharmacology 18:156.
Snyder, R., and J. J. Kocsis. 1975. Current concepts of chronic benzene toxicity. CRC Crit. Rev. Tox icol. 3:265–288.
Snyder, R., and H. Remmer. 1979. Classes of hepatic microsomal mixed function oxidase inducers. Pharmacol. Ther. 7:213–244.
Snyder, R. F., F. Uzuki, L. Gonasun, E. Bromfeld, and A. Wells. 1967. The metabolism of benzene in vitro. Toxicol. Appl. Pharmacol. 11:346–360.
Snyder, R., E. W. Lee, and J. J. Kocsis. 1978a. Binding of labeled benzene metabolites to mouse liver and bone marrow. Res. Commun. Chem. Pathol. Pharmacol. 20:191–194.
Snyder, R., E. W. Lee, and J. J. Kocsis. 1978b. Minireview: Bone marrow depressant and leukemogenic actions of benzene. Life Sci. 21:1709–1722.
Snyder, R., S. L. Longacre, C. M. Witmer, J. J. Kocsis, L. S. Andrews, and E. W. Lee. 1980. Biochemical toxicology of benzene. Pp. 123–153 in E. Hodgson, J. R. Bend, and R. M. Philpot, eds. Reviews in Biochemical Toxicology ,Volume 3. Elsevier/North-Holland, New York.
Snyder, R., D. V. Parke, J. J. Kocsis, D. J. Jollow, G. G. Gibson, and C. W. Witmer, eds. 1982. Bio logical Reactive Intermediates. II. Clinical Mechanisms and Biological Effects. Plenum Press, New York. 1476 pp.
Thorgeirsson, S. S., H. A. Sasame, J. R. Mitchell, D. J. Jollow, and W. Z. Potter. 1976. Biochemical changes after hepatic injury from toxic doses of acetaminophen or furosemide. Pharmacology 14:205–217.
Williams, R. T. 1959. Detoxification Mechanisms: The Mechanism and Detoxication of Drugs, Toxic Substances and Other Organic Compounds. Wiley, New York.
Williams, R. T., and D. V. Parke. 1964. The metabolic fate of drugs. Annu. Rev. Pharmacol. 4:85–114.
Yang, S. K., J. Duetsch, and H. V. Gelboin. 1978. Benzo(a)pyrene metabolism, activation and detoxification. Pp. 205–231 in H. V. Gelboin and P. O. P. Ts’o, eds. Polycyclic Hydrocarbons and Cancer. Volume 1. Environment, Chemistry and Metabolism. Academic Press, New York.
Zampaglione, N., D. J. Jollow, J. R. Mitchell, B. Stripp, M. Hamrick, and J. R. Gillette. 1973. Role of detoxifying enzymes in bromobenzene-induced liver necrosis. J. Pharmacol. Exp. Ther. 187:218–227.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1987 Plenum Press, New York
About this chapter
Cite this chapter
Andrews, L.S., Longacre, S.L., Snyder, R. (1987). Application of in Vivo Data on Chemical—Biological Interactions. In: Tardiff, R.G., Rodricks, J.V. (eds) Toxic Substances and Human Risk. Life Science Monographs. Springer, New York, NY. https://doi.org/10.1007/978-1-4684-5290-7_13
Download citation
DOI: https://doi.org/10.1007/978-1-4684-5290-7_13
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4684-5292-1
Online ISBN: 978-1-4684-5290-7
eBook Packages: Springer Book Archive